Radius Health Inc. (RDUS) Reveals an Earnings Mystery – News Heater
Home  »  Business   »  Radius Health Inc. (RDUS) Reveals an Earnings Myst...

Radius Health Inc. (RDUS) Reveals an Earnings Mystery

Radius Health Inc. (NASDAQ:RDUS) went up by 9.02% from its latest closing price compared to the recent 1-year high of $23.00. The company’s stock price has collected 34.16% of gains in the last five trading sessions.

Is It Worth Investing in Radius Health Inc. (NASDAQ :RDUS) Right Now?

Plus, the 36-month beta value for RDUS is at 0.65. Opinions of the stock are interesting as 0 analysts out of 8 who provided ratings for Radius Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 7 rated it as “hold,” and 1 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $9.00, which is -$0.9 below the current price. RDUS currently public float of 47.35M and currently shorts hold a 17.68% ratio of that float. Today, the average trading volume of RDUS was 871.04K shares.

RDUS’s Market Performance

RDUS stocks went up by 34.16% for the week, with a monthly jump of 57.36% and a quarterly performance of 11.94%, while its annual performance rate touched -52.53%. The volatility ratio for the week stands at 13.11% while the volatility levels for the past 30 days are set at 8.64% for Radius Health Inc. The simple moving average for the period of the last 20 days is 35.33% for RDUS stocks with a simple moving average of -10.13% for the last 200 days.

Analysts’ Opinion of RDUS

Many brokerage firms have already submitted their reports for RDUS stocks, with BofA Securities repeating the rating for RDUS by listing it as a “Neutral.” The predicted price for RDUS in the upcoming period, according to BofA Securities is $8 based on the research report published on June 08th of the current year 2022.

SVB Leerink, on the other hand, stated in their research note that they expect to see RDUS reach a price target of $7. The rating they have provided for RDUS stocks is “Mkt Perform” according to the report published on May 23rd, 2022.

Morgan Stanley gave a rating of “Underweight” to RDUS, setting the target price at $7 in the report published on December 10th of the previous year.

RDUS Trading at 33.20% from the 50-Day Moving Average

After a stumble in the market that brought RDUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.04% of loss for the given period.

Volatility was left at 8.64%, however, over the last 30 days, the volatility rate increased by 13.11%, as shares surge +47.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.11% lower at present.

During the last 5 trading sessions, RDUS rose by +34.16%, which changed the moving average for the period of 200-days by -32.97% in comparison to the 20-day moving average, which settled at $6.94. In addition, Radius Health Inc. saw 32.80% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RDUS starting from BIOTECH TARGET N V, who purchase 477,824 shares at the price of $5.57 back on May 18. After this action, BIOTECH TARGET N V now owns 8,733,538 shares of Radius Health Inc., valued at $2,661,002 using the latest closing price.

BIOTECH TARGET N V, the 10% Owner of Radius Health Inc., purchase 300,000 shares at $6.31 during a trade that took place back on Jan 06, which means that BIOTECH TARGET N V is holding 8,255,714 shares at $1,894,410 based on the most recent closing price.

Stock Fundamentals for RDUS

Current profitability levels for the company are sitting at:

  • -23.62 for the present operating margin
  • +91.52 for the gross margin

The net margin for Radius Health Inc. stands at -30.51. Equity return is now at value 29.40, with -40.70 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.83.

Is Everbridge Inc. (EVBG) a Keeper?

Everbridge Inc. (NASDAQ:EVBG) went down by -5.59% from its latest closing price compared to the recent 1-year high of $167.40. The company’s stock price has